Latest operating income for ALIM: $850K.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2024
Trailing 12 months ending Jun 30, 2024
Alimera Sciences (ALIM) currently reports a operating income of $850K as of June 2024. That compares with $-10M in the prior-year period — up 108.5% year over year. Use the charts on this page to explore Alimera Sciences's operating income history and peer comparisons.
Alimera Sciences's operating income increased from $-10M to $850K — a 108.5% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Alimera Sciences reported $850K in operating income as of June 2024. That compares with $-10M in the prior-year period — up 108.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $850K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alimera Sciences, and consider following ALIM for alerts when major investors trade the stock.
Alimera Sciences is classified in the Healthcare sector. On operating income, it currently shows $850K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALIM with unrelated industries.